Dermatology News and Research RSS Feed - Dermatology News and Research

Dermatology is the branch of medicine dealing with the skin and its diseases. Dermatologists take care of diseases and cancers of the skin, scalp, hair, and nails.
Alcohol consumption linked to higher risk of melanoma

Alcohol consumption linked to higher risk of melanoma

Alcohol intake was associated with higher rates of invasive melanoma among white men and women. [More]
Acne: when to seek help?

Acne: when to seek help?

Acne develops due to an interplay between genetic factors (so people often have a family history) and hormonal factors that can increase the size and activity of the sebaceous or oil gland. [More]
Allergan gets FDA approval for new XEN Glaucoma Treatment System

Allergan gets FDA approval for new XEN Glaucoma Treatment System

Allergan plc announced today the U.S. Food and Drug Administration has cleared the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) for use in the U.S. [More]
Study shows new drug combination effective in treating precancerous skin lesions

Study shows new drug combination effective in treating precancerous skin lesions

A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the therapy activates the immune system's T cells, which then attack the abnormal skin cells. [More]
Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Allergan, Amgen submit BLA for ABP 215 oncology biosimilar medicine to FDA

Amgen and Allergan plc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 215, a biosimilar candidate to Avastin (bevacizumab). [More]
Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan plc, a leading global pharmaceutical company, today announced the availability of TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1mg/20mcg, the first and only oral contraceptive in a softgel capsule for the prevention of pregnancy [More]
Study shows many indoor tanning facilities comply with Texas under-18 ban

Study shows many indoor tanning facilities comply with Texas under-18 ban

When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81 percent of indoor tanning facilities complied with the Texas ban on indoor tanning for those under the age of 18 in a study conducted by The University of Texas MD Anderson Cancer Center. [More]

Person's risk factor status may help tailor surveillance program for melanomas, study suggests

The new study, published online today by JAMA Dermatology, identifies high risk patients who may benefit from tailored surveillance. [More]
Dermatologists offer tips to help men develop healthy skin care routines

Dermatologists offer tips to help men develop healthy skin care routines

When it comes to skin care, men have traditionally kept it simple. However, experts say more men are now pursuing healthier, younger-looking skin. [More]
Scientists develop new strategy to stop uncontrollable poison ivy itch

Scientists develop new strategy to stop uncontrollable poison ivy itch

Scientists at Duke Health and Zhejiang Chinese Medical University have developed a strategy to stop the uncontrollable itch caused by urushiol, the oily sap common to poison ivy, poison sumac, poison oak and even mango trees. [More]
FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis. [More]
Myriad Genetics presents research data that validates accuracy of myPath Melanoma test

Myriad Genetics presents research data that validates accuracy of myPath Melanoma test

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced it will present two new studies at the American Society of Dermatopathology (ASDP) annual meeting being held Oct. 27-30, 2016 in Chicago, Ill. [More]
Novel nanofiber coating shows potential to prevent bacterial infections of orthopaedic prostheses

Novel nanofiber coating shows potential to prevent bacterial infections of orthopaedic prostheses

In a proof-of-concept study with mice, scientists at The Johns Hopkins University show that a novel coating they made with antibiotic-releasing nanofibers has the potential to better prevent at least some serious bacterial infections related to total joint replacement surgery. [More]
Novel approach may speed up development of new drugs against skin disease

Novel approach may speed up development of new drugs against skin disease

In an ideal world, the newest and most effective drugs for chronic inflammatory conditions would immediately help everyone who took them. [More]

Bio-Oil introduces new campaign to support people living with scars

Specialist skincare brand, Bio-Oil, has launched a new campaign to support people living with scarring. The campaign was devised in response to research demonstrating the considerable impact felt by people living with scarring on their psychological wellbeing. [More]
New study highlights need for routine skin cancer screening for all transplant patients

New study highlights need for routine skin cancer screening for all transplant patients

A new study from Drexel University College of Medicine suggests all organ transplant recipients, regardless of race, should receive routine, total-body screenings for skin cancer. [More]
JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

JAK inhibitors show promise in restoring hair growth in patients with alopecia areata

Seventy-five percent of patients with moderate to severe alopecia areata--an autoimmune disease that causes patchy, and less frequently, total hair loss--had significant hair regrowth after treatment with ruxolitinib, reported researchers from Columbia University Medical Center. By the end of their treatment, average hair regrowth was 92 percent. [More]
Novartis presents new findings from global psoriasis survey at EADV Congress

Novartis presents new findings from global psoriasis survey at EADV Congress

Novartis presented new findings from the largest global survey to date of people with psoriasis, showing many do not achieve the treatment goal of clear skin or even believe it is a realistic goal. [More]
Study opens door towards personalized medicine for children with eczema

Study opens door towards personalized medicine for children with eczema

Atopic dermatitis, or eczema, is a common skin disorder that usually starts by 5 years of age, but virtually all of the studies that have defined the immune changes underlying eczema and are directing new treatment options have been done in adult skin. [More]
Two Zika vaccine candidates protect newborn mice against neurological damage

Two Zika vaccine candidates protect newborn mice against neurological damage

Two vaccines against Zika virus developed at the University of Pittsburgh School of Medicine have successfully conveyed immunity from female mice to pups conceived weeks after the mother's vaccination. [More]
Advertisement